<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4332</number>
    <updateDate>2022-03-02T16:39:41Z</updateDate>
    <updateDateIncludingText>2022-03-02T16:39:41Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2012-03-29</introducedDate>
    <congress>112</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. PALLONE:H.R. 4332.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3The Congress shall have power to regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.[Page H1806]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2012-03-30T18:36:18Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2012-03-29T13:05:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Food and Drug Administration Reform Act of 2012</title>
        <congress>112</congress>
        <number>5651</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2012-06-04</actionDate>
          <text>Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 420.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2012-03-30</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2012-03-29</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2012-03-29</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2012-03-29</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>6</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000558</bioguideId>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <firstName>Brett</firstName>
        <lastName>Guthrie</lastName>
        <party>R</party>
        <state>KY</state>
        <district>2</district>
        <sponsorshipDate>2012-03-29</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001142</bioguideId>
        <fullName>Rep. Matheson, Jim [D-UT-2]</fullName>
        <firstName>JIM</firstName>
        <lastName>MATHESON</lastName>
        <party>D</party>
        <state>UT</state>
        <district>2</district>
        <sponsorshipDate>2012-04-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001248</bioguideId>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <firstName>Michael</firstName>
        <lastName>Burgess</lastName>
        <party>R</party>
        <state>TX</state>
        <middleName>C.</middleName>
        <district>26</district>
        <sponsorshipDate>2012-04-24</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000355</bioguideId>
        <fullName>Rep. Dingell, John D. [D-MI-15]</fullName>
        <firstName>JOHN</firstName>
        <lastName>DINGELL</lastName>
        <party>D</party>
        <state>MI</state>
        <middleName>D.</middleName>
        <district>15</district>
        <sponsorshipDate>2012-04-25</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000197</bioguideId>
        <fullName>Rep. DeGette, Diana [D-CO-1]</fullName>
        <firstName>DIANA</firstName>
        <lastName>DEGETTE</lastName>
        <party>D</party>
        <state>CO</state>
        <district>1</district>
        <sponsorshipDate>2012-05-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000613</bioguideId>
        <fullName>Rep. Dold, Robert J. [R-IL-10]</fullName>
        <firstName>Robert</firstName>
        <lastName>Dold</lastName>
        <party>R</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <district>10</district>
        <sponsorshipDate>2012-05-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative remedies</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Executive agency funding and structure</name>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2012-03-29</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2012-05-21T19:07:07Z</updateDate>
        <text><![CDATA[ <p>Generic Drug Application Review Fairness Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to extend from 30 to 60 months after application the period for a first applicant of a generic drug to obtain tentative approval without forfeiting the 180-day exclusivity period with respect to such drug, unless the failure in meeting the extended period is caused by a change in or review of approval requirements. Limits extension coverage to applications filed within 30 months preceding the enactment of this Act.</p> <p>Reduces such extended period by six months per year over a five-year period, beginning on October 1, 2013.</p> <p>Directs the Secretary of Health and Human Services (HHS) to maintain the Office of Generic Drugs as a separate office within the Center for Drug Evaluation and Research of the Food and Drug Administration (FDA).</p>]]></text>
      </summary>
    </summaries>
    <title>Generic Drug Application Review Fairness Act of 2012</title>
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Generic Drug Application Review Fairness Act of 2012</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Generic Drug Application Review Fairness Act of 2012</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes.</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2012-03-29T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-112hr4332ih/xml/BILLS-112hr4332ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2012-03-30</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
